MM - 1329
Mortality, Thrombotic, Hemorrhagic, and Cardiovascular Outcomes With First-Line Carfilzomib Versus Bortezomib in Adults With Multiple Myeloma: A Real-World Propensity-Matched Analysis
Chanchal Maheshwari
Poster Presenter: Chanchal Maheshwari